Johnson & Johnson has said it will stop selling talc-based baby powder products globally next year, two years after halting sales in the US and Canada.
Johnson & Johnson has agreed to pay more than $100 million to settle over 1,000 lawsuits that allege the company’s Baby Powder talc products caused cancer, according to Bloomberg.
Johnson & Johnson lawyers are gearing up to appeal a court ruling, which rewarded billions to 22 women in a case linking ovarian cancer and use of J&J's signature Baby Powder.
Amgen has rebuffed claims made by an analyst suggesting that its obesity drug MariTide is associated with reductions in bone mineral density that could undermine its ability to compete in t
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.